Uptake of influenza vaccination in patients on immunosuppressant agents for rheumatological diseases: A follow-up audit of the influence of secondary care [1]

Rheumatology

Volumn 46, Issue 4, 2007, Pages 715-716

  Doe, S ^a   Pathare, S ^a   Kelly, C A ^a   Heycock, C R ^a   Binding, J ^a   Hamilton, J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; METHOTREXATE; STEROID; STREPTOCOCCUS VACCINE;

ADULT; AGED; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; IMMUNIZATION; INFLUENZA; LETTER; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATIC DISEASE; STREPTOCOCCUS INFECTION; TREATMENT REFUSAL; VACCINATION;

ADULT; AGED; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MEDICAL AUDIT; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RHEUMATIC DISEASES; VACCINATION;

EID: 34047111334     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel410     Document Type: Letter

References (11)

1. Gluck T. Vaccinate your immunocompromised patients! Rheumatology 2006;45:9-10.
2. BSR National guidelines for the monitoring of second line drugs. London: British Society for Rheumatology, 2000.
3. Summary of Flu immunisation policy - Department of health. http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/Flu.
4. Bridges MJ, Coady D, Kelly CA et al. Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:685.
5. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski M. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of literature. Ann Intern Med 1995;123:518-27.
6. Centres for Disease Control and Prevention. Recommended adult immunisation schedule - United States, October 2004 - September 2005. MMWR 2004; 53:Q1-Q4. Available at http://www.cdc.gov/nip/recs/ adult-schedule.htm.
7. STIKO. Hinweise zu Impfungen fur Patienten mit Immundefizienz. Epidemiol Bull 2005:353-64. Available at http://www.rki.de.
8. PL CMO (2004) 4: Update on the influenza and pneumococcal immunisation programmes. http://www.dh.gov.uk.
9. SEHD/CMO(2004)15. Influenza immunization programme for 2004-05, Pneumococcal immunization programme for 2004-5.
10. Kapetanovic MC, Saxne T, Sjoholm A et al. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 2006;45:106-111.
11. British Society for rheumatology. Vaccinations in immunocompromised persons - guidelines for the patient taking immunosuppressants, steroids and the new biologic therapies. London: British Society for Rheumatology, 2002 (www.rheumatology.org.uk).